Elected to the NAM, four faculty members earn the highest honor in biomedicine

Four faculty members from the Perelman School of Medicine have been elected to the National Academy of Medicine (NAM), one of the nation's highest honors in biomedicine. 

NAM is an independent organization of professionals from diverse fields, including health and medicine, and the natural, social, and behavioral sciences. Its mission is to improve health for all by advancing science, accelerating health equity, and providing independent, authoritative, and trusted advice nationally and globally.

Top row: Susan M. Domchek, Rachel M. Werner. Bottom row: Daniel Polsky, Celeste Simon. Photos courtesy of Penn Medicine News.

Susan M. Domchek is the Basser Professor in Oncology, executive director of the Basser Center for BRCA at the Abramson Cancer Center, director of the MacDonald Women's Cancer Risk Evaluation Center, and a senior fellow at the Leonard Davis Institute of Health Economics. She is a nationally recognized breast and ovarian cancer expert. Rachel M. Werner is a professor of medicine and of health care management in the Wharton School, director of Health Policy and Outcomes Research in the department of Medicine, and associate chief for research in the division of General Internal Medicine. Her research has examined the use of financial incentives to improve health care quality, and the unintended consequences that often accompany them. 

Daniel E. Polsky is a professor of medicine, the executive director of the Leonard Davis Institute of Health Economics, and the Robert D. Eilers Professor of Health Care Management in the Wharton School. He is a health economist nationally recognized for advancing the fundamental understanding of the tradeoffs between quality of care and health spending, and the methodology for economic evaluations within randomized clinical trials. And Marie Celeste Simon is the Arthur H. Rubenstein, MBBCh Professor in the department of Cell and Developmental Biology, the scientific director of Abramson Family Cancer Research Institute, and the associate director of the Abramson Cancer Center Core Facilities. Her laboratory studies cancer cell metabolism, tumor immunology, metastasis, and cellular responses to oxygen deprivation. 

Read more at Penn Medicine News.